TCOM Stock Analysis: Trip.com | NASDAQ
Travel Services | NASDAQ, USA | Market Cap: 28.324m USD | 12M Return: -29.2% | US89677Q1076 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 116M
EPS Trend: 92.7%
Qual. Beats: 0
Rev. Trend: 95.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Trip.com Group Limited (NASDAQ: TCOM) is a major online travel service provider headquartered in Singapore, operating across China and international markets. Through subsidiaries, the company offers a broad portfolio of travel services including accommodation reservation, transportation ticketing (air, train, long-distance bus, and ferry), packaged tours, in-destination products, and corporate travel management. It primarily acts as an agent for hotel bookings and air ticket sales, and operates under multiple well-known travel brands including Ctrip, Qunar, Trip.com, Travix, Travelfusion, and Skyscanner.
The company also generates ancillary revenue streams beyond traditional bookings, such as travel insurance, online check-in and seat selection, airport VIP lounge access, online advertising, and financial services targeting both consumers and ecosystem partners. Its corporate travel arm, Trip.Biz, delivers technology-enabled business travel management solutions, adding an enterprise-focused segment to its predominantly consumer-facing platform model. Founded in 1999 and formerly known as Ctrip.com International (renamed in October 2019), Trip.com is classified within the Consumer Discretionary sector and the Hotels, Resorts & Cruise Lines sub-industry.
- China outbound travel recovery fuels hotel and ticketing revenue
- Skyscanner international bookings drive diversification beyond China
- Competition from Meituan pressures hotel take rates and margins
| Net Income: 31.4b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.50 > 1.0 |
| NWC/Revenue: 65.98% < 20% (prev 64.31%; Δ 1.68% < -1%) |
| CFO/TA 0.05 > 3% & CFO 14.4b > Net Income 31.4b |
| Net Debt (-48.9b) to EBITDA (36.6b): -1.34 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (681.7m) vs 12m ago -2.91% < -2% |
| Gross Margin: 80.33% > 18% (prev 81.06%; Δ -0.73% > 0.5%) |
| Asset Turnover: 25.29% > 50% (prev 22.29%; Δ 3.00% > 0%) |
| Interest Coverage Ratio: 52.87 > 6 (EBIT TTM 35.7b / Interest Expense TTM 675.7m) |
| A: 0.16 (Total Current Assets 123b - Total Current Liabilities 80.3b) / Total Assets 262b |
| B: 0.29 (Retained Earnings 76.6b / Total Assets 262b) |
| C: 0.14 (EBIT TTM 35.7b / Avg Total Assets 255b) |
| D: 1.71 (Book Value of Equity 165b / Total Liabilities 96.1b) |
| Altman-Z'' = 4.75 = AA |
| DSRI: 1.04 (Receivables 16.2b/13.4b, Revenue 64.5b/55.2b) |
| GMI: 1.01 (GM 81.06% / 80.33%) |
| AQI: 0.97 (AQ_t 0.51 / AQ_t-1 0.52) |
| SGI: 1.17 (Revenue 64.5b / 55.2b) |
| TATA: 0.07 (NI 31.4b - CFO 14.4b) / TA 262b) |
| Beneish M = -2.88 (Cap -4..+1) = A |
As of August 19, 2026, the stock is trading at USD 44.55 with a total of 1,920,254 shares traded. Over the past week, the price has changed by -3.57%, over one month by +0.81%, over three months by -9.67% and over the past year by -29.23%.
Current recommended Stop Loss: 43.20 (which is 3% or 1.2 ATR below the current price).
Trip.com has received a consensus analysts rating of 4.64. Therefore, it is recommended to buy TCOM.
- StrongBuy: 24
- Buy: 6
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 60.4 | 35.5% |
Market Cap CNY = 191b (28.3b USD * 6.7433 USD.CNY)
P/E Trailing = 6.7134
P/E Forward = 15.8983
P/S = 0.4372
P/B = 1.1567
P/EG = 1.9112
Revenue TTM = 64.5b CNY
EBIT TTM = 35.7b CNY
EBITDA TTM = 36.6b CNY
Long Term Debt = 10.7b CNY (from longTermDebt, last quarter)
Short Term Debt = 20.0b CNY (from shortTermDebt, last quarter)
Debt = 31.8b CNY (from shortLongTermDebtTotal, last quarter) + Leases 542.0m
Net Debt = -48.9b CNY (calculated: Debt 31.8b - CCE 80.7b)
Enterprise Value = 142b CNY (191b + Debt 31.8b - CCE 80.7b)
Interest Coverage Ratio = 52.87 (Ebit TTM 35.7b / Interest Expense TTM 675.7m)
EV/FCF = 10.46x (Enterprise Value 142b / FCF TTM 13.6b)
FCF Yield = 9.56% (FCF TTM 13.6b / Enterprise Value 142b)
FCF Margin = 21.07% (FCF TTM 13.6b / Revenue TTM 64.5b)
Net Margin = 48.76% (Net Income TTM 31.4b / Revenue TTM 64.5b)
Gross Margin = 80.33% ((Revenue TTM 64.5b - Cost of Revenue TTM 12.7b) / Revenue TTM)
Gross Margin QoQ = 79.45% (prev 78.96%)
Tobins Q-Ratio = 0.54 (Enterprise Value 142b / Total Assets 262b)
Interest Expense / Debt = 2.13% (Interest Expense 675.7m / Debt 31.8b)
Taxrate = 16.11% (6.05b / 37.6b)
NOPAT = 30.0b (EBIT 35.7b * (1 - 16.11%))
Current Ratio = 1.53 (Total Current Assets 123b / Total Current Liabilities 80.3b)
Debt / Equity = 0.19 (Debt 31.8b / totalStockholderEquity, last quarter 165b)
Debt / EBITDA = -1.34 (Net Debt -48.9b / EBITDA 36.6b)
Debt / FCF = -3.60 (Net Debt -48.9b / FCF TTM 13.6b)
Total Stockholder Equity = 163b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.33% (Net Income 31.4b / Total Assets 262b)
RoE = 19.28% (Net Income TTM 31.4b / Total Stockholder Equity 163b)
RoCE = 20.55% (EBIT 35.7b / Capital Employed (Equity 163b + L.T.Debt 10.7b))
RoIC = 15.08% (NOPAT 30.0b / Invested Capital 199b)
WACC = 7.01% (E(191b)/V(223b) * Re(7.88%) + D(31.8b)/V(223b) * Rd(2.13%) * (1-Tc(0.16)))
Discount Rate = 7.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 58.21 | Cagr: 0.88%
[DCF] Terminal Value 73.10% ; FCFF base≈15.8b ; Y1≈13.8b ; Y5≈11.2b
[DCF] Fair Price = 362.4 (EV 179b - Net Debt -48.9b = Equity 228b / Shares 629.7m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 92.69 | EPS CAGR: 54.38% | SUE: -0.01 | # QB: 0
Revenue Correlation: 95.50 | Revenue CAGR: 23.66% | SUE: 0.05 | # QB: 0
EPS current Quarter (2026-06-30): EPS=5.66 | Chg30d=-8.43% | Revisions=-73% | Analysts=14
EPS next Quarter (2026-09-30): EPS=7.95 | Chg30d=-2.39% | Revisions=-70% | Analysts=11
EPS current Year (2026-12-31): EPS=24.27 | Chg30d=-3.52% | Revisions=-86% | GrowthEPS=-46.8% | GrowthRev=+8.1%
EPS next Year (2027-12-31): EPS=28.52 | Chg30d=-1.50% | Revisions=-85% | GrowthEPS=+17.5% | GrowthRev=+11.5%
[Analyst] Revisions Ratio: -94% (up=0, down=50)